SEDATION SHOWDOWN: BARBITURATES VS. BENZODIAZEPINES │ EP117
Show notes
In this episode, we’re covering barbiturates and benzodiazepines, two drug classes that both act at the GABA-A receptor but have important differences in their pharmacology, clinical effects, and reversal.
In this episode:
- How barbiturates and benzodiazepines modify the GABA-A receptor
- Why barbiturates increase chlo ride channel duration while benzodiazepines increase frequency
- Methohexital, thiopental, midazolam, diazepam, and lorazepam
- Key pharmacokinetic and clinical differences between the major drugs
- Flumazenil reversal and the board-relevant risks you need to remember
This episode is part of our 12-week SEE/NCE podcast series, designed to follow the Atomic Anesthesia SEE/NCE Study Plan week by week.
Want to study along with the episode? Join the Atomic Anesthesia learning platform to get the accompanying worksheet, plus access to our members-only podcast episodes and additional SEE/NCE study resources.
FREE RESOURCE FOR THIS EPISODE:
SEE/NCE Study Plan — A structured, week-by-week plan to pass your boards. Head to atomicanesthesia.com/freebies/see-nce-study-plan to grab it free.
WANT THE FULL PLATFORM?
Atomic Anesthesia is the all-in-one study platform built specifically for SRNAs: 800 lessons, 10,000 quiz questions, flashcards, and interactive features. Join at atomicanesthesia.com.
Mentioned in this episode:
💜 PARTNERS: The Incomologists®
https://theincomologists.com/ You work hard caring for others—let us take care of you. Whether you’re a W-2 employee or transitioning to a 1099 role, we understand the unique challenges healthcare professionals face, from insurance coverage to financial planning. That’s where we step in. Like you, we are a team of healthcare providers who understand your needs and help you find tailored insurance plans and financial strategies without the hassle or pressure. And we’re a partner you can rely on, today and in the future. We evaluate all available options and resources in the market to protect our clients, so contact us, and we’ll get started! - Jake Bevilacqua, CRNA ([email protected])